<unk> (oral) is a serotonin (5-HT)1B/1D receptor agonist that is FDA approved for the treatment of migraine with or without aura.   Common adverse reactions include neck/throat/jaw pain/tightness/pressure, dizziness, paresthesia, asthenia, somnolence, warm/cold sensation, nausea, heaviness sensation, and dry mouth.
Zolmitriptan 
Sumatriptan 
Eletriptan
Rizatriptan
Frovatriptan
Almotriptan
Naratriptan
Olopatadine 